Trials of implanted heart monitor begin:
This article was originally published in Clinica
Trials of a pacemaker-sized implant which monitors heart failure patients have begun in Sweden. The Chronicle device, made by US firm Medtronic, is implanted in the pectoral region of the patient and measures blood pressure inside the heart as well as heart rate and activity levels. Data is stored and sent telemetrically to a monitor so that the doctor can tailor drug therapy. The first implant was performed on a 70-year-old man at the Karolinska Hospital in Stockholm.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.